Reference Citation Analysis: Find an Article, Find a Category, Find a Journal, Find a Scholar

For: Wang ML, Chen EQ. Editorial: switching to tenofovir alafenamide monotherapy is effective and safe for other nucleos(t)ide analogues-treated patients with chronic hepatitis B. Aliment Pharmacol Ther 2022;56:1090-1091. [PMID: 35995741 DOI: 10.1111/apt.17122] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 01/17/2023]

For:	Wang ML, Chen EQ. Editorial: switching to tenofovir alafenamide monotherapy is effective and safe for other nucleos(t)ide analogues-treated patients with chronic hepatitis B. Aliment Pharmacol Ther 2022;56:1090-1091. [PMID: 35995741 DOI: 10.1111/apt.17122] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 01/17/2023]

Number

Cited by Other Article(s)

Ogawa E. Editorial: switching to tenofovir alafenamide monotherapy is effective and safe for other nucleos(t)ide analogues-treated patients with chronic hepatitis B - author's reply. Aliment Pharmacol Ther 2022;56:1092-1093. [PMID: 35995743 DOI: 10.1111/apt.17173] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 12/09/2022]